Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Prospective Evaluation of Targeted Axillary Dissection (TAD)

Study ID: NCT04998682
Start Date: 2022-03-01
End Date: 2026-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Axillary Dissection

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Study ID: NCT05079282
Start Date: 2021-12-10
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

217

Intervention / Treatment

ONO-4685

Sponsor

Ono Pharmaceutical Co. Ltd

Source: clinicaltrials.gov

Share:
Add to list

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Study ID: NCT06146920
Start Date: 2024-01-10
End Date: 2028-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

39

Intervention / Treatment

Evaluation of ctDNA using the F1T after 1 year of immunotherapy

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

Study ID: NCT04373720
Start Date: 2020-03-20
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Magnetic Resonance Elastography

Magnetic Resonance Imaging

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Pilot and Feasibility Study of a Dietary Intervention with Low-protein Meals in Cancer Patients Receiving Immunotherapies

Study ID: NCT05356182
Start Date: 2022-05-04
End Date: 2025-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Diet

Sponsor

State University of New York at Buffalo

Source: clinicaltrials.gov

Share:
Add to list

Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

Study ID: NCT05464082
Start Date: 2023-01-06
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Functional Precision Oncology

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, the PARRC Trial

Study ID: NCT06770582
Start Date: 2025-12-02
End Date: 2032-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

Biospecimen Collection

Cisplatin

Computed Tomography

Fluorouracil

Gemcitabine

Magnetic Resonance Imaging

Mitomycin

Pembrolizumab

Administration questionnaire

Radiation Therapy

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Study ID: NCT06263231
Start Date: 2024-06-28
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

333

Intervention / Treatment

INT230-6

Eribulin

Trabectedin

On the feopanib

Sponsor

Intensity Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Study ID: NCT06106282
Start Date: 2023-07-12
End Date: 2028-07-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Non-Interventional Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

CER-1236 in Patients With Acute Myeloid Leukemia (AML)

Study ID: NCT06834282
Start Date: 2025-04-07
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

CER-1236

Cyclophosphamide

Fludarabine

Meat

Sponsor

CERo Therapeutics Holdings, Inc.

Source: clinicaltrials.gov

Share:
Add to list